Dinesh D Satone

Learn More
The objective of the current study was to develop a validated, specific stability-indicating reversed-phase liquid chromatographic (LC) method for the quantitative determination of escitalopram oxalate and clonazepam and their related substances in bulk drugs and pharmaceutical dosage forms in the presence of degradation products. Forced degradation studies(More)
A simple, accurate and precise spectrophotometric method has been developed for simultaneous estimation of escitalopram oxalate and clonazepam in combined dosage form. Simultaneous equation method is employed for simultaneous determination of escitalopram oxalate and clonazepam from combined dosage forms. In this method, the absorbance was measured at 238(More)
The robustness and specificity of the LC method were established. Changes in the chromatographic system (column, mobile phase, pH, wavelength, and temperature) were used to evaluate the robustness. The retention time observed allowed a rapid determination of the drug, which is important for routine analysis. The use of mobile phase with out buffer which(More)
  • 1